Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
56 studies found for:    (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals
Condition: HIV
Interventions: Drug: MVA.HIVconsv vaccine;   Drug: Romidepsin
22 Unknown  Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects
Condition: HIV Infection
Intervention: Biological: Hepavax-Gene
23 Recruiting Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda
Condition: HIV/AIDS and Infections
Intervention: Biological: Hepatitis B vaccine
24 Unknown  7-valent Pneumococcal Conjugated Vaccination
Condition: Invasive Pneumococcal Disease
Intervention: Biological: 7-valent pneumococcal conjugated vaccine
25 Recruiting Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
Condition: HIV
Interventions: Biological: pSG2.HIVconsv DNA vaccine;   Biological: ChAdV63.HIVconsv booster vaccine;   Biological: MVA.HIVconsv booster vaccine;   Drug: CPHPC;   Other: Placebo
26 Not yet recruiting REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Condition: HIV/AIDS
Intervention: Biological: REMUNE
27 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
28 Not yet recruiting Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected Patients
Condition: HIV Infection
Interventions: Biological: DCV3;   Biological: DCV3 with PEG-INF;   Biological: Placebo;   Biological: Placebo with PEG-INF
29 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Interventions: Biological: Gardasil;   Drug: Placebo
30 Recruiting The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo
Condition: HIV
Interventions: Biological: GTU®-MultiHIV B Clade Vaccine;   Other: Sodium chloride BP
31 Not yet recruiting iHIVARNA Clinical Trial in HIV Infected Individuals
Condition: HIV Infections
Interventions: Biological: iHIVARNA-01;   Biological: TriMix;   Biological: Placebo
32 Unknown  Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes
Condition: HIV
Intervention: Biological: GTU®-multiHIV B clade
33 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
34 Recruiting Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: PNC Vaccine;   HIV-infected Pregnant Women
Interventions: Biological: PPV-23;   Biological: PCV-10;   Other: NaCl
35 Recruiting Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults
Condition: Healthy
Interventions: Biological: Ad26.Mos.HIV;   Biological: Ad26.Mos4.HIV;   Biological: Clade C gp140;   Drug: Placebo
36 Unknown  Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)
Conditions: HPV Infection;   HIV Infection;   Syphilis
37 Unknown  Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
38 Recruiting A T Cell-based HIV Vaccine
Condition: HIV
Interventions: Other: HIV positive subjects;   Other: Non-infected control subjects
39 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
40 Recruiting Research In Viral Eradication of HIV Reservoirs
Condition: HIV
Interventions: Drug: Combination Antiretroviral Therapy (cART);   Drug: Raltegravir;   Drug: Vorinostat;   Biological: ChAdV63.HIVconsv (ChAd);   Biological: MVA.HIVconsv (MVA)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-56) Show next page of results    Last Page
Indicates status has not been verified in more than two years